Oncological outcomes of neoadjuvant chemotherapy in patients with resectable synchronous colorectal liver metastasis: A result from a propensity score matching study

BACKGROUND: The efficacy and safety of neoadjuvant chemotherapy (NAC) in treating resectable synchronous colorectal liver metastases (CRLM) remain controversial. METHODS: Data from CRLM patients who underwent simultaneous liver resection between January 2015 and December 2019 were collected from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yu-Juan, Zhou, Si-Cheng, Chen, Jing-Hua, Liang, Jian-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623041/
https://www.ncbi.nlm.nih.gov/pubmed/36330479
http://dx.doi.org/10.3389/fonc.2022.951540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623041/
https://www.ncbi.nlm.nih.gov/pubmed/36330479
http://dx.doi.org/10.3389/fonc.2022.951540

Ejemplares similares